Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Prenetics Partners with ACON Bio to Launch Flowflex(TM) COVID-19 Home Antigen Test in Hong Kong - the Most Accurate Test in the Market 2022-02-25 09:53
Insilico Announces Successful Completion of Phase 0 Microdose Trial and Initiates Phase I Clinical Trial for its First AI-discovered Anti-fibrotic Product Candidate with Novel Target 2022-02-25 00:00
Orpha Labs AG Announces the Initiation of a Phase III Trial Evaluating ORL-101 for Treatment of Leukocyte Adhesion Deficiency Type II 2022-02-23 21:27
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2022 Financial Results 2022-02-23 20:00
Sirnaomics Announces Interim Data from Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma 2022-02-23 17:53
World BioEconomy Forum talks on climate - live from Ruka! 2022-02-23 16:00
RosVivo Therapeutics, Inc. signed a Material Transfer Agreement (MTA) for first-in-class diabetes treatment with Eli Lilly and Company 2022-02-22 20:52
Innovent Announces First Patient Dosing of Universal "Modular" CAR-T Cell product IBI345 2022-02-21 08:00
Small Molecule Targeting CD47-SIRPα Pathway: Insilico Medicine Achieves its First Major Milestone in Fosun Pharma Collaboration with the Nomination of Preclinical Candidate for QPCTL 2022-02-17 16:30
BioWorld by Clarivate Provides In-depth Analyses of Long COVID Studies, Potentially the Next Public Health Crisis 2022-02-17 16:00
Kato Wins FDA Approval for Human Studies of Drug for Retinal Disorders 2022-02-17 12:14
CStone Pharmaceuticals Announces the Acceptance of New Drug Application (NDA) for Pralsetinib for the Treatment of RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC) and RET-Altered Thyroid Cancers in Taiwan, China 2022-02-17 09:19
Innovent Announces Two Registration Studies of IBI306 (anti-PCSK-9 antibody) Met Primary Endpoint 2022-02-17 08:00
Sirnaomics Receives Safe to Proceed Letter for U.S. FDA Investigational New Drug Application for Systemic RNAi Therapeutic STP707 in Primary Sclerosing Cholangitis (PSC) 2022-02-16 17:04
NIBIOHN, Shionogi Discover Host Immune-dependent Novel Anti-coronavirus Antibody 2022-02-16 14:00
Delos Capital Announces $300 Million First Close of its Third Life Sciences Fund 2022-02-15 23:59
Goodwin Biotechnology Announces the Appointment of Darrin T. Schellin as Chief Executive Officer 2022-02-15 22:35
Travecta Therapeutics Appoints Leading Experts to Expand its Scientific Advisory Leadership Team 2022-02-15 21:00
HPG: New Breakthrough in Virus Inactivation with Green Tea Catechin (EGCg) 2022-02-15 16:00
Recbio Provides Updates on First Lyophilized mRNA Vaccine and Pre-clinical Data Showing Long-term stability and Strong immunogenicity against SARS-CoV-2 2022-02-15 12:57
1 96 97 98 99 100 224